Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Differential expression levels of microRNAs associated with time to progression in patients with GBM

From: Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

microRNAs Time To Progression(TTP)
< 9 months > 9 months p-value < 12 months > 12 months p-value < 15 months > 15 months p-value
hsa-miR-128b 7.56 ± 0.76 7.59 ± 0.74 0.6587 7.54 ± 0.75 7.67 ± 0.76 0.2028 7.53 ± 0.73 7.76 ± 0.81 0.0420
hsa-miR-323 6.19 ± 0.29 6.20 ± 0.28 0.5988 6.18 ± 0.29 6.22 ± 0.28 0.3012 6.18 ± 0.29 6.26 ± 0.30 0.0451
hsa-miR-329 6.06 ± 0.19 6.07 ± 0.21 0.6787 6.05 ± 0.20 6.07 ± 0.21 0.4293 6.05 ± 0.19 6.10 ± 0.22 0.0981
hsa-miR-106a 9.77 ± 0.77 9.95 ± 0.67 0.0439 9.77 ± 0.75 10.03 ± 0.67 0.0091 9.79 ± 0.73 10.03 ± 0.75 0.0305
hsa-miR-106b 10.69 ± 0.67 10.93 ± 0.58 0.0021 10.73 ± 0.67 10.91 ± 0.56 0.0398 10.75 ± 0.65 10.88 ± 0.60 0.1980
hsa-miR-21 14.22 ± 1.11 14.01 ± 1.04 0.1136 14.23 ± 1.07 13.86 ± 1.09 0.0089 14.23 ± 1.07 13.74 ± 1.08 0.0029
hsa-miR-92 10.15 ± 0.62 10.28 ± 0.64 0.0795 10.16 ± 0.62 10.32 ± 0.65 0.0497 10.16 ± 0.60 10.38 ± 0.71 0.0214